LAB Research announces changes to its board of directors
As part of the conditions of the Standby Purchase agreement signed at the time of the
"To date, the Fund has been a very supportive shareholder which shares our vision of making LRI one of the world-leading providers of non-clinical services to the health care market. The recent participation of the Fund in the Rights Offering has been a key contributing factor of its success, and we look forward to working with
About LAB Research Inc.:
LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petro-chemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in
LAB Research's shares trade on The
This news release contains certain forward-looking statements that reflect the current views and/or expectations of LAB Research Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.
%SEDAR: 00023798EFFor further information: Luc Mainville, Chief Executive Officer, (450) 973-2240 (ext. 1206), email@example.com, www.labresearch.com; Frédéric Dumais, Partner, Jasmin-Dumais Financial Communications, (514) 862-1251, firstname.lastname@example.org